🌍 We're exactly 1 month away from the #SCDM Single Day Event in South Africa! On August 22, 2025, #SCDM returns to Bloemfontein under the theme “Data Management 2030: Embracing Innovation and Advancing Our Future” to explore what the future of clinical data looks like—and how

Quality In, Quality Out. But what happens in between? As eCOA adoption grows, it’s reshaping the #clinicaldata landscape - bringing new opportunities, but also new risks. While other systems have advanced, eCOA lags behind, leaving #DataManagers under pressure to clean, query,

In clinical trials, risk is inevitable. But how we manage it? That’s where transformation begins. At #SCDM25, we’re spotlighting a session that redefines what’s possible in Risk-Based Data Management (#RBDM). You'll discover: 🔍 How analytics can uncover hidden patterns before

Why is it essential to keep the GCDMP© up to date? Because it’s more than a guideline — it’s the standard that ensures #clinical #trial data is accurate, consistent, and credible. To maintain that standard, expert review is key. Right now, the chapter on “Design and

At #EMEA26, we’re not just talking about the future of clinical data science - we’re building it. And we want you to help shape the conversation. Whether you're a data visionary, a tech disruptor, or a champion of operational excellence, this is your chance to lead. Submit a

What does it take to design eCOA that works - for data managers, for patients, and for the future of #trials? As #eCOA becomes a central source of clinical trial data, the pressure to get it right is growing. This webinar brings together two experts who’ve worked across

Ever been ghosted by your Gen Z CDM after 'slaying' the kickoff call? At #SCDM25, we’re diving into the generational dynamics reshaping clinical data teams. From quiet quitting to slaying deliverables - Gen Z is changing the game. But are we ready? Let's find at in Baltimore

What do bridges and clinical trials have in common? At #EMEA26, we’re drawing inspiration from Copenhagen’s iconic Øresund Bridge - because just like cities, #clinicaltrials thrive when connections are strong. Connections between fragmented data. Between cross-functional teams.

Early phase trials are evolving. Are you? As trial designs grow more complex and data streams multiply, the traditional #CDM role is being stretched thin. At #SCDM25, Reema Deb, Terri Sampo, MPH, and Bo Zheng will explore how the Clinical Data Scientist is stepping in - not

Partnerships in Clinical Trials — a podcast series exploring the alliances that shape the future of #clinicalresearch. Hosted by Patrick Nadolny, 2024 SCDM Chair, each episode dives into the evolving relationships between key stakeholders: patient advocates, site

Ever wondered what really happens inside an FDA submission review? Not just the forms and formats - but the metadata, the tools, the reviewer’s lens, and the evolving standards shaping tomorrow’s submissions. At #SCDM25, the pre-conference workshop “Data Requirements for an FDA

Clinical trials don’t build themselves. Neither do bridges. At #EMEA26, we’re inviting you to help shape the future of #clinicaldata by submitting a session proposal that connects ideas, teams, and technologies. Whether you're working on smarter data flows, patient-centric

What’s next for Clinical Data Science? You tell us. Submit your session proposal for #EMEA26 and share your outlook on the course of the CDM industry. This year we're focusing on how tomorrow's trials will be shaped by: ✔️ How we connect fragmented data ✔️ Align

Still haven’t explored the Spring Issue of #JSCDM? It’s a reflection of where we are and where we’re heading. Grounded in #SCDM’s 2030 Vision. jscdm.org/issue/34/info/ Dr Lauren Houston Takuhiro Yamaguchi

What happens in Baltimore shouldn’t stay in Baltimore. That’s why we’re excited to have Veeva Systems as our Platinum Sponsor at #SCDM25 — helping us capture and share the conversations that matter most. From keynote insights to hallway debates, Veeva Systems is supporting the

We’re using AI to make clinical development smarter. But are we smart about how we use AI? That’s the question Munenori Takata will explore at #SCDM25 — and it’s not just rhetorical. Generative AI is already reshaping how we diagnose, analyze, and manage #clinicaldata. But

Explore the #regulatory and #operational dimensions of biospecimen data governance in a new podcast episode. In this sponsored episode, originally produced by Slope, Rust Felix CEO and Co-founder of Slope, sits down with legal and regulatory expert Edye Edens to unpack a

Your learning. Your way. The new #SCDM Learning Experience Platform - elev8 - is more than a library of courses. It’s a personalized journey that adapts to your pace and goals. It's interactive and makes concepts stick. It's ready to provide on-the-spot answers. It's built

Oversight Isn’t Optional Anymore. Are You Inspection-Ready? ICH E6(R3) is reshaping how sponsors approach oversight and inspectors are watching closely. In this hands-on webinar from Revvity Signals, three experts - Christie Quarles, Brent Meyers, and Philip Ross - break down

AI-Powered Oversight Starts with Smarter Workflows As Annexes 2 and 3 approach, clinical data teams must evolve from delegation to independent oversight. During the next #SCDM industry webinar brought to you by Revvity Signals , Christie Quarles, Philip Ross and Brent Meyers